- Home
- ZIP vs FTRE Comparison
ZIP vs FTRE Comparison
Compare ZIP & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIP | FTRE |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 829.3M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ZIP | FTRE |
|---|---|---|
| Price | $2.00 | $9.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $3.88 | ★ $15.39 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $448,952,000.00 | ★ $2,723,400,000.00 |
| Revenue This Year | $1.00 | N/A |
| Revenue Next Year | $5.93 | $3.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1.00 |
| 52 Week Low | $1.65 | $3.97 |
| 52 Week High | $6.55 | $18.67 |
Technical Indicators
Market Signals| Indicator | ZIP | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 43.95 | 44.76 |
| Support Level | $1.68 | $8.85 |
| Resistance Level | $2.59 | $11.22 |
| Average True Range (ATR) | 0.19 | 0.65 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 31.55 | 58.39 |
Price Performance
Historical ComparisonAbout ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace that connects job seekers and employers through an AI-powered platform. The company provides recruiting solutions that help employers identify and hire qualified candidates while enabling job seekers to discover relevant job opportunities through intelligent matching and recommendation tools.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.